Share this article
Share this article
SAN FRANCISCO, May 12, 2021 /PRNewswire/ The global large molecule bioanalytical technologies market size is expected
to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated
to expand at a CAGR of 13.5% from 2021 to 2028. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.
Key suggestions from the report:
The product segment accounted for the largest revenue share in 2020
Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
The latest research report on
Residues and Contamination Testing Market was conducted across a variety of industries in various regions to provide a report that has data surpassing 100+ pages (Based on 2020 COVID-19 Worldwide Spread) The report offers a mixture of qualitative and quantifiable information focusing on aspects such as key market developments, industry and competitors’ challenges in gap analysis and new opportunities in the Residues and Contamination Testing market. Various leaders along with players that are emerging, have been profiled in this report.
The attention on the overwhelming players
Eurofins Scientific, SGS SA, Intertek Group plc, ALS Limited, SCS Global Services, Microbac Laboratories, Inc., Symbio Laboratories, AsureQuality, Mérieux NutriSciences, Bureau Veritas, NSF International, TÜV SÜD, AB Sciex, Scicorp Laboratories PTY Ltd, Neogen Corporation, IDEXX Laboratories, Inc., Charm Sciences, VICAM, Campden BRI, Arbro Pharmaceuticals Pvt. Ltd., J
Share this article
SELBYVILLE, Del., Jan. 20, 2021 /PRNewswire/ According to latest report U.S. Cannabis Testing Market by Technology (Chromatography, Spectroscopy), Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), Zonal Outlook, Price Trends, Competitive Market Share & Forecast 2027 , by Global Market Insights, Inc., the market valuation of cannabis testing in the United States will cross $4.1 billion by 2027.
U.S. cannabis testing market for liquid chromatography (LC) segment exceeded USD 662.4 million in 2020 due to half of the cannabis testing procedures are completed through LC.
Stringent regulatory policies to ensure the availability of high-quality cannabis for the treatment of various medical conditions and recreational use will spur the demand for U.S. cannabis testing services during the forecast timeframe. Moreover, the FDA has several resources available that address cannabis s